LIANY — LianBio
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1831283 ·
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Sep 2023 | 0 | 0 | -26,301,000 | -24,039,000 | 262,902,000 | 103,457,000 | 26,790,000 |
| Jun 2023 | 0 | 0 | -25,044,000 | -21,621,000 | 278,798,000 | 104,059,000 | 23,293,000 |
| Mar 2023 | 0 | 0 | -25,969,000 | -24,045,000 | 302,583,000 | 102,334,000 | 28,156,000 |
| Sep 2022 | 0 | 0 | -24,549,000 | -21,897,000 | 351,842,000 | 78,862,000 | 45,244,000 |
Annual Trend (SEC EDGAR, last 2y)
Revenues vs Net Income (last 2y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2022 | 0 | -125,353,000 | -110,290,000 | 319,960,000 | 26,313,000 | 259,873,000 | -99,185,000 |
| Dec 2021 | 0 | -195,570,000 | -196,300,000 | 426,343,000 | 39,007,000 | 353,562,000 | -163,953,000 |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-87,981,000
OpCashFlow TTM
—
Assets (Latest)
$262,902,000
Forward EPS
$-0.36
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| LLY | ELI LILLY & Co | $1.04T | $1169.60 | — |
| JNJ | JOHNSON & JOHNSON | $618.09B | $256.48 | — |
| ABBV | AbbVie Inc. | $481.40B | $272.42 | — |
| MRK | Merck & Co., Inc. | $351.28B | $142.38 | — |
| NVS | NOVARTIS AG | $272.01B | $143.11 | — |
News headlines (Yahoo Finance, 1h cache)
Recent Insider Activity
No insider activity indexed for this ticker.